Publication | Closed Access

Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer

Klf5 ExpressionBreast OncologyNovel Mifepristone DerivativesMedicinePharmacologyBreast CancerTumor TargetingTriple-negative Breast CancerAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentTumor BiologyDrug Discovery